Mark Giaquinto was diagnosed with Parkinson's disease five years ago and continues to combat the illness with a positive ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Marc Cohn is walking in his truth. The 65-year-old singer, whose “Walking in Memphis” single took the world by storm in the ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

The manufacturer of AV-101, an investigational, oral nonopioid, NMDA-targeting therapy to treat neuropathic pain, announced that it has received a U.S. patent for the treatment. AV-101 (4-Cl-KYN) is ...

Men, more than women, are at risk of developing Parkinson's disease, which is a progressive degenerative disorder of the nervous system that leads to hand tremors. But hand tremors alone cannot ...

New research from McGill University reveals that listening to music at your own rhythm can significantly reduce pain.

Music has the best chance of providing pain relief when it is played at our natural rhythm, a McGill University research team ...

This is not the kind of honor I ever anticipated on my life bingo card. But I never expected a Parkinson’s disease diagnosis, either. Or starting a foundation that bears my name, which has ...

“I am talking about chronic pain, addiction, neurooncology ... treatment for movement disorders such as essential tremor and Parkinson’s disease. (Mike Stocker/South Florida Sun Sentinel ...